Creating Value Through Strategic Pharmaceutical Partnerships
GMEP works with pharmaceutical partners through in-licensing, out-licensing, marketing authorization acquisition, co-development and distribution-based commercialization models.
GMEP is advancing a pipeline of 15+ pharmaceutical products focused on differentiated formulations, value-added medicines and international commercialization opportunities. These projects support future regulatory development in Europe and selected global markets.
GMEP seeks differentiated pharmaceutical products with clear market potential for Europe and selected international markets.
GMEP is developing multiple pharmaceutical product pipelines and is preparing regulatory submissions in the European Union and selected international markets. We welcome discussions with partners interested in licensing opportunities, regional commercialization and market expansion.
GMEP is open to acquiring or managing existing marketing authorizations, mature products and selected pharmaceutical assets with redevelopment potential.
GMEP works with development and manufacturing partners to build pharmaceutical products for Europe and global markets.
GMEP connects pharmaceutical products with suitable distribution and commercial partners across selected territories.
Territory-based or product-based licensing cooperation.
Acquisition or management of pharmaceutical assets.
Joint development and commercialization.
Commercial partner identification and market expansion.
Long-term business cooperation.
